DLL3 Gene Spondylocostal Dysostosis Autosomal Recessive Type 1 Genetic Test
Welcome to DNA Labs UAE, your trusted genetic testing laboratory in the UAE. Today, we will be discussing the DLL3 Gene Spondylocostal Dysostosis Autosomal Recessive Type 1 Genetic Test. This test is designed to diagnose and analyze the genetic disorder known as spondylocostal dysostosis, autosomal recessive type 1 (SCDO1).
Test Details
The DLL3 gene is associated with SCDO1, a rare genetic disorder that affects the development of the spine and ribs, leading to abnormalities in these structures. Our Next-Generation Sequencing (NGS) technology allows us to analyze multiple genes simultaneously, making it an effective tool for identifying mutations or variations in the DLL3 gene.
Test Components and Price
The DLL3 Gene Spondylocostal Dysostosis Autosomal Recessive Type 1 Genetic Test is priced at AED 4400.0. The test requires a blood sample, extracted DNA, or one drop of blood on an FTA Card. The report will be delivered within 3 to 4 weeks.
Test Method
We utilize NGS technology for this test, which allows for accurate and efficient analysis of the DLL3 gene. This advanced sequencing technology enables us to identify specific genetic mutations or variations that may be causing SCDO1.
Test Type and Doctor
The DLL3 Gene Spondylocostal Dysostosis Autosomal Recessive Type 1 Genetic Test falls under the category of Osteology Dermatology Immunology Disorders. It is recommended to consult with a dermatologist for this specific test.
Test Department and Pre Test Information
The DLL3 Gene Spondylocostal Dysostosis Autosomal Recessive Type 1 Genetic Test is conducted in our Genetics department. Before undergoing the test, it is important to provide the clinical history of the patient who will be tested. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected by SCDO1.
Benefits and Future Implications
By identifying specific genetic mutations or variations in the DLL3 gene, the DLL3 Gene Spondylocostal Dysostosis Autosomal Recessive Type 1 Genetic Test can help confirm a diagnosis of SCDO1. This information is crucial for genetic counseling, family planning, and potential treatment options. Furthermore, the test contributes to ongoing research efforts aimed at better understanding the genetic basis of SCDO1 and developing targeted therapies in the future.
At DNA Labs UAE, we are committed to providing accurate and reliable genetic testing services. If you suspect you or a family member may have SCDO1, we encourage you to consult with a dermatologist and consider undergoing the DLL3 Gene Spondylocostal Dysostosis Autosomal Recessive Type 1 Genetic Test. Early diagnosis can lead to better management and improved quality of life.
Test Name | DLL3 Gene Spondylocostal dysostosis autosomal recessive type 1 Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Osteology Dermatology Immunology Disorders |
Doctor | Dermatologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for DLL3 Gene Spondylocostal dysostosis, autosomal recessive type 1 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with DLL3 Gene Spondylocostal dysostosis, autosomal recessive type 1 NGS Genetic DNA Test gene DLL3 |
Test Details |
The DLL3 gene is associated with a rare genetic disorder called spondylocostal dysostosis, autosomal recessive type 1 (SCDO1). This disorder affects the development of the spine and ribs, leading to abnormalities in these structures. NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technology to analyze multiple genes simultaneously. In the case of SCDO1, NGS genetic testing can be used to identify mutations or variations in the DLL3 gene that may be causing the disorder. By identifying specific genetic mutations or variations, NGS genetic testing can help confirm a diagnosis of SCDO1 and provide valuable information for genetic counseling, family planning, and potential treatment options. It can also help researchers better understand the genetic basis of the disorder and potentially develop targeted therapies in the future. |